| Pharmaceutical active ingredients: |
| Oxymetazoline Hydrochloride |
| Available forms, composition and doses of Nasivinetten gegen Schnupfen: |
| N / A |
| Nasivinetten gegen Schnupfen medical category: |
| Human:Nasal decongestants and other nasal preparationsOphthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AA05 - OxymetazolineR01AB07 - OxymetazolineS01GA04 - Oxymetazoline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Merck |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nasivin | Oxymetazoline Hydrochloride | Merck; Bracco; Chugai Pharmaceutical; Gulf Pharmaceutical Industries, Julphar; Iromedica; Neopharm, Israel; Nycomed; Seven Seas; Zuellig Pharma |
| Nasivin gegen Schnupfen | Oxymetazoline Hydrochloride | Merck |
| Nasivin Pur | Oxymetazoline Hydrochloride | Merck; Iromedica |
| Nasivin Sanft | Oxymetazoline Hydrochloride | Merck |
| Nasivine | Oxymetazoline Hydrochloride | Merck; Iromedica |
| Nasivinettes | Oxymetazoline Hydrochloride | Merck; Viatris |
| Nasolina | Oxymetazoline Hydrochloride | Salvat Laboratorios |
| Nasorhinathiol | Oxymetazoline Hydrochloride | Sanofi-Aventis |
| Nasovalda | Oxymetazoline Hydrochloride | GlaxoSmithKline |
| Nazol | Oxymetazoline Hydrochloride | Sagmel |